Katherine L Henderson

Katherine L Henderson


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2023 in Journal of Hospital Infection
Verified
Journal Article
Open access
KHKatherine L Henderson
Katherine L Henderson
ASA. Saei
A. Saei
RFR. Freeman
R. Freeman
AJA.P. Johnson
A.P. Johnson
DAD. Ashiru-Oredope
D. Ashiru-Oredope
SHS. Hopkins
S. Hopkins
Background: Point prevalence surveys are an important surveillance method for deter-mining the burden of healthcare-associated infections (HCAIs). Aim: To outline the key results of two point prevalence surveys in England (2011 and 2016). Methods: All National Health Service and independent sector hospitals in England were eligible to participate. Data were collected between September and November in both 2011 and 2016 based on the protocol and codebook devised by the European Centre for Disease Prevention and Control. Analysis was performed using Stata Version 13 and SAS Version 9.3. A mixed-effects model was applied, which allowed estimation of organization-specific means and accounted for the heterogeneity in the responses from different organizations. Findings: A total of 100,755 case records were included (52,433 in 2011 and 48,312 in 2016). The estimated prevalence of HCAIs was slightly higher in 2016 [6.89%, 95% con-fidence interval (CI) 6.21-7.57%] than in 2011 (6.41%, 95% CI 5.75-7.06%). In both surveys, the prevalence of HCAIs was highest in adult intensive care units (23.1% in 2011, 21.2% in 2016), and pneumonia/lower respiratory tract infections was the most common cause of HCAIs (22.7% in 2011 vs 29.2% in 2016). Inpatients in acute hospitals were older and had higher risk of dying in 2016 compared with 2011; however, the proportion of inpatients with HCAIs or on antibiotics did not differ significantly. Conclusion: The burden of HCAIs in English hospitals increased slightly between 2011 and 2016. However, the proportion of inpatients with HCAIs or on antibiotics did not differ significantly. & COPY; 2023 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.

24 March 2023 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
RGRebecca Guy
Rebecca Guy
HHHannah Higgins
Hannah Higgins
JRJamie Rudman
Jamie Rudman
HFHolly Fountain
Holly Fountain
KBKirsty Bennet
Kirsty Bennet
KHKatherine L Henderson
Katherine L Henderson
The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) antimicrobial resistance (AMR) chapter reports on bacterial, viral, and fungal AMR trends between 2017 and 2021 in England. A 10.8% increase in patient episodes of bacteraemia or fungaemia was observed, and the estimated burden of resistance decreased by 4.2%. Individuals with an antimicrobial-resistant strain (resistant to ≥1 key AMR burden-defined antibiotics) had a higher crude case fatality rate (18.1%) compared to those with a susceptible strain (16.3%). The effect of deprivation on carbapenemase-producing organisms (CPO) incidence, and the impact of the AMR burden across ethnic groups, have been described for the first time. Understanding the impact of ethnicity, deprivation, regional divergence, and potential confounders remains a crucial avenue of enquiry to target appropriate AMR interventions. These findings were presented at the ESPAUR Report webinar on 23 November 2022.

30 November 2023 in medRxiv
Verified
Preprint
Open access
PDF file
KVKarina-Doris Vihta
Karina-Doris Vihta
EPEmma Pritchard
Emma Pritchard
KPKoen Pouwels
Koen Pouwels
SHSusan Hopkins
Susan Hopkins
RGRebecca Guy
Rebecca Guy
DEDavid W. Eyre
David W. Eyre
Objectives: Predicting antimicrobial resistance (AMR), a top global health threat, nationwide at a hospital level could help target interventions. Using machine learning, we exploit historical AMR and antimicrobial usage to predict future AMR. Methods: Antimicrobial use and AMR prevalence in bloodstream infections in hospitals in England were obtained per hospital group (Trust) and financial year (FY, April-March) for 22 pathogen-antibiotic combinations (FY2016-2017-FY2021-2022). XGBoost model predictions were compared to previous value taken forwards, difference between the previous two years taken forwards and linear trend forecasting (LTF). XGBoost feature importances were calculated to aid interpretability. Results: Relatively limited year-to-year variability in AMR prevalence within Trust-pathogen-antibiotic combinations meant previous value taken forwards achieved a low mean absolute error (MAE). XGBoost models performed similarly, while difference between the previous two years taken forwards and LTF were consistently worse. XGBoost considerably outperformed all other methods in Trusts with a larger change in AMR prevalence from FY2020-2021 (last training year) to FY2021-2022 (held-out test set). Feature importance values indicated that complex relationships were exploited for predictions. Conclusion: Year-to-year resistance has generally changed little within Trust-pathogen-antibiotic combinations. In those with larger changes, XGBoost models could improve predictions, enabling informed decisions, efficient resource allocation, and targeted interventions.